Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Cholecystokinin 8 (CCK8) ,etc. by FLIA (Flow Luminescence Immunoassay)
Sincalide; Cholecystokinin 8, Octapeptide
(Note: Up to 8-plex in one testing reaction)
- Product No.LMB044Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length3h
- Detection Range0.98-1000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.327 pg/mL.
- DownloadInstruction Manual
- UOM 8Plex 7Plex 6Plex 5Plex 4Plex 3Plex 2Plex1Plex
- FOB
US$ 415
US$ 431
US$ 455
US$ 487
US$ 519
US$ 567
US$ 638
US$ 798
Add to Price Calculator
Result
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Cholecystokinin 8 (CCK8).
No significant cross-reactivity or interference between Cholecystokinin 8 (CCK8) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Cholecystokinin 8 (CCK8) and the recovery rates were calculated by comparing the measured value to the expected amount of Cholecystokinin 8 (CCK8) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 86-101 | 93 |
| EDTA plasma(n=5) | 80-98 | 91 |
| heparin plasma(n=5) | 83-97 | 87 |
| sodium citrate plasma(n=5) | 86-102 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cholecystokinin 8 (CCK8) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cholecystokinin 8 (CCK8) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cholecystokinin 8 (CCK8) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 89-96% | 78-93% | 82-92% | 90-101% |
| EDTA plasma(n=5) | 80-99% | 81-92% | 85-103% | 99-105% |
| heparin plasma(n=5) | 96-105% | 98-105% | 87-103% | 85-92% |
| sodium citrate plasma(n=5) | 78-90% | 95-103% | 79-91% | 84-102% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| 96-well plate | 1 | Plate sealer for 96 wells | 4 |
| Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
| Pre-Mixed Magnetic beads (22#:CCK8) | 1 | Analysis buffer | 1×20mL |
| Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
| Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
| Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
| Instruction manual | 1 |
Assay procedure summary
1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 50μL standard or sample to each well, add 50μL prepared Detection Reagent A, add 10μL magnetic beads, and incubate 90 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
5. Wash plate once on magnetic frame;
6. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| World J Gastroenterol | Roles of sphincter of Oddi motility and serum vasoactive intestinal peptide, gastrin and cholecystokinin octapeptide NCBI: PMC4000510 |
| Epilepsy Research | A prospective study on changes in blood levels of cholecystokinin-8 and leptin in patients with refractory epilepsy treated with the ketogenic diet. pubmed:27568597 |
| Journal of Ethnopharmacology | Luhong formula inhibits myocardial fibrosis in a paracrine manner by activating thegp130/JAK2/STAT3 pathway in cardiomyocytes. pubmed:28115285 |
| Untersuchungen zu verschiedenen biochemischen Markern des zentralen Nervensystems im Liquor cerebrospinalis von Patienten mit der Huntington-Krankheit : | |
| Journal of Functional Foods | The protective effect of Capparis spinosa fruit on triptolide-induced acute liver injury: A metabolomics-based systematic study |

